Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction

Non-small-cell lung cancer is one of the most lethal cancers in the worldwide. Although Paclitaxel-based combinational therapies have long been used as a standard treatment in aggressive non-small-cell lung cancers, Paclitaxel resistance emerges as a major clinical problem. It has been demonstrated...

Full description

Bibliographic Details
Main Authors: Yimin Lu, Jun Wang, Lei Liu, Lequn Yu, Nian Zhao, Xingju Zhou, Xudong Lu
Format: Article
Language:English
Published: IOS Press 2017-04-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317698353
_version_ 1818413863079510016
author Yimin Lu
Jun Wang
Lei Liu
Lequn Yu
Nian Zhao
Xingju Zhou
Xudong Lu
author_facet Yimin Lu
Jun Wang
Lei Liu
Lequn Yu
Nian Zhao
Xingju Zhou
Xudong Lu
author_sort Yimin Lu
collection DOAJ
description Non-small-cell lung cancer is one of the most lethal cancers in the worldwide. Although Paclitaxel-based combinational therapies have long been used as a standard treatment in aggressive non-small-cell lung cancers, Paclitaxel resistance emerges as a major clinical problem. It has been demonstrated that Curcumin from Curcuma longa as a traditional Chinese medicine can inhibit cancer cell proliferation. However, the role of Curcumin in Paclitaxel-resistant non-small-cell lung cancer cells is not clear. In this study, we investigated the effect of Curcumin on the Paclitaxel-resistant non-small-cell lung cancer cells and found that Curcumin treatment markedly increased the sensitivity of Paclitaxel-resistant non-small-cell lung cancer cells to Paclitaxel. Mechanically, the study revealed that Curcumin could reduce the expression of metastasis-associated gene 1 (MTA1) gene through upregulation of microRNA-30c in Paclitaxel-resistant non-small-cell lung cancer cells. During the course, MTA1 reduction sensitized Paclitaxel-resistant non-small-cell lung cancer cells and enhanced the effect of Paclitaxel. Taken together, our studies indicate that Curcumin increases the sensitivity of Paclitaxel-resistant non-small-cell lung cancer cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction. Curcumin might be a potential adjuvant for non-small-cell lung cancer patients during Paclitaxel treatment.
first_indexed 2024-12-14T11:09:57Z
format Article
id doaj.art-c555812da68a4c6b89239c90df4f54ab
institution Directory Open Access Journal
issn 1423-0380
language English
last_indexed 2024-12-14T11:09:57Z
publishDate 2017-04-01
publisher IOS Press
record_format Article
series Tumor Biology
spelling doaj.art-c555812da68a4c6b89239c90df4f54ab2022-12-21T23:04:21ZengIOS PressTumor Biology1423-03802017-04-013910.1177/1010428317698353Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reductionYimin Lu0Jun Wang1Lei Liu2Lequn Yu3Nian Zhao4Xingju Zhou5Xudong Lu6Department of Respiratory, The First People’s Hospital of Kunshan Affiliated to Jiangsu University, Suzhou, ChinaDepartment of Respiratory, Suzhou Kowloon Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Suzhou, ChinaDepartment of Respiratory, The First People’s Hospital of Kunshan Affiliated to Jiangsu University, Suzhou, ChinaDepartment of Respiratory, The First People’s Hospital of Kunshan Affiliated to Jiangsu University, Suzhou, ChinaDepartment of Respiratory, The First People’s Hospital of Kunshan Affiliated to Jiangsu University, Suzhou, ChinaDepartment of Respiratory, The First People’s Hospital of Kunshan Affiliated to Jiangsu University, Suzhou, ChinaDepartment of Respiratory, The First People’s Hospital of Kunshan Affiliated to Jiangsu University, Suzhou, ChinaNon-small-cell lung cancer is one of the most lethal cancers in the worldwide. Although Paclitaxel-based combinational therapies have long been used as a standard treatment in aggressive non-small-cell lung cancers, Paclitaxel resistance emerges as a major clinical problem. It has been demonstrated that Curcumin from Curcuma longa as a traditional Chinese medicine can inhibit cancer cell proliferation. However, the role of Curcumin in Paclitaxel-resistant non-small-cell lung cancer cells is not clear. In this study, we investigated the effect of Curcumin on the Paclitaxel-resistant non-small-cell lung cancer cells and found that Curcumin treatment markedly increased the sensitivity of Paclitaxel-resistant non-small-cell lung cancer cells to Paclitaxel. Mechanically, the study revealed that Curcumin could reduce the expression of metastasis-associated gene 1 (MTA1) gene through upregulation of microRNA-30c in Paclitaxel-resistant non-small-cell lung cancer cells. During the course, MTA1 reduction sensitized Paclitaxel-resistant non-small-cell lung cancer cells and enhanced the effect of Paclitaxel. Taken together, our studies indicate that Curcumin increases the sensitivity of Paclitaxel-resistant non-small-cell lung cancer cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction. Curcumin might be a potential adjuvant for non-small-cell lung cancer patients during Paclitaxel treatment.https://doi.org/10.1177/1010428317698353
spellingShingle Yimin Lu
Jun Wang
Lei Liu
Lequn Yu
Nian Zhao
Xingju Zhou
Xudong Lu
Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction
Tumor Biology
title Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction
title_full Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction
title_fullStr Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction
title_full_unstemmed Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction
title_short Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction
title_sort curcumin increases the sensitivity of paclitaxel resistant nsclc cells to paclitaxel through microrna 30c mediated mta1 reduction
url https://doi.org/10.1177/1010428317698353
work_keys_str_mv AT yiminlu curcuminincreasesthesensitivityofpaclitaxelresistantnsclccellstopaclitaxelthroughmicrorna30cmediatedmta1reduction
AT junwang curcuminincreasesthesensitivityofpaclitaxelresistantnsclccellstopaclitaxelthroughmicrorna30cmediatedmta1reduction
AT leiliu curcuminincreasesthesensitivityofpaclitaxelresistantnsclccellstopaclitaxelthroughmicrorna30cmediatedmta1reduction
AT lequnyu curcuminincreasesthesensitivityofpaclitaxelresistantnsclccellstopaclitaxelthroughmicrorna30cmediatedmta1reduction
AT nianzhao curcuminincreasesthesensitivityofpaclitaxelresistantnsclccellstopaclitaxelthroughmicrorna30cmediatedmta1reduction
AT xingjuzhou curcuminincreasesthesensitivityofpaclitaxelresistantnsclccellstopaclitaxelthroughmicrorna30cmediatedmta1reduction
AT xudonglu curcuminincreasesthesensitivityofpaclitaxelresistantnsclccellstopaclitaxelthroughmicrorna30cmediatedmta1reduction